The use of health economics to guide drug development decisions: Determining optimal values for an RSV-vaccine in a model-based scenario-analytic approach

  • JM Bos
  • , E (Edwin) Rietveld
  • , Henriette Moll
  • , Ewout Steyerberg
  • , W Luytjes
  • , Janneke Wilschut
  • , Ronald Groot
  • , MJ Postma

Research output: Contribution to journalArticleAcademicpeer-review

13 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)6922-6929
Number of pages8
JournalVaccine
Volume25
DOIs
Publication statusPublished - 2007

Research programs

  • EMC MM-04-54-08-A
  • EMC NIHES-02-65-01

Cite this